These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25093740)

  • 21. [New strategies for assessing the risk of sudden cardiac death in hypertrophic cardiomyopathy].
    Jaworski K; Możeńska O; Kosior DA
    Pol Merkur Lekarski; 2016 Aug; 41(242):65-9. PubMed ID: 27591441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
    Pokorski RJ
    J Insur Med; 2002; 34(1):43-60. PubMed ID: 15303593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM).
    O'Mahony C; Jichi F; Ommen SR; Christiaans I; Arbustini E; Garcia-Pavia P; Cecchi F; Olivotto I; Kitaoka H; Gotsman I; Carr-White G; Mogensen J; Antoniades L; Mohiddin SA; Maurer MS; Tang HC; Geske JB; Siontis KC; Mahmoud KD; Vermeer A; Wilde A; Favalli V; Guttmann OP; Gallego-Delgado M; Dominguez F; Tanini I; Kubo T; Keren A; Bueser T; Waters S; Issa IF; Malcolmson J; Burns T; Sekhri N; Hoeger CW; Omar RZ; Elliott PM
    Circulation; 2018 Mar; 137(10):1015-1023. PubMed ID: 29191938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.
    Cotiga D; Ehlert F; Sherrid M
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():55-60. PubMed ID: 17162272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy.
    Magrì D; Limongelli G; Re F; Agostoni P; Zachara E; Correale M; Mastromarino V; Santolamazza C; Casenghi M; Pacileo G; Valente F; Musumeci B; Maruotti A; Volpe M; Autore C
    Heart; 2016 Apr; 102(8):602-9. PubMed ID: 26849900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
    Ostman-Smith I
    Fundam Clin Pharmacol; 2010 Oct; 24(5):637-52. PubMed ID: 20727015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy.
    Miller MA; Gomes JA; Fuster V
    Nat Clin Pract Cardiovasc Med; 2007 Dec; 4(12):667-76. PubMed ID: 18033231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transatlantic differences in assessment of risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Jahnlová D; Tomašov P; Zemánek D; Veselka J
    Int J Cardiol; 2015; 186():3-4. PubMed ID: 25804453
    [No Abstract]   [Full Text] [Related]  

  • 29. Sudden death in hypertrophic cardiomyopathy.
    Maron BJ
    J Cardiovasc Transl Res; 2009 Dec; 2(4):368-80. PubMed ID: 20559995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sports and Exercise in Athletes with Hypertrophic Cardiomyopathy.
    Alpert C; Day SM; Saberi S
    Clin Sports Med; 2015 Jul; 34(3):489-505. PubMed ID: 26100424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification.
    Maron BJ
    Cardiol Clin; 2007 Aug; 25(3):399-414, vi. PubMed ID: 17961794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differing strategies for sudden death prevention in hypertrophic cardiomyopathy.
    Maron MS; Rowin E; Spirito P; Maron BJ
    Heart; 2023 Mar; 109(8):589-594. PubMed ID: 36270782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up.
    Dimitrow PP; Chojnowska L; Rudzinski T; Piotrowski W; Ziólkowska L; Wojtarowicz A; Wycisk A; Dabrowska-Kugacka A; Nowalany-Kozielska E; Sobkowicz B; Wróbel W; Aleszewicz-Baranowska J; Rynkiewicz A; Loboz-Grudzien K; Marchel M; Wysokinski A
    Eur Heart J; 2010 Dec; 31(24):3084-93. PubMed ID: 20843960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
    Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    O'Mahony C; Elliott PM
    Heart; 2014 Feb; 100(3):254-60. PubMed ID: 23574968
    [No Abstract]   [Full Text] [Related]  

  • 37. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
    Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
    J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertrophic cardiomyopathy in children.
    Moak JP; Kaski JP
    Heart; 2012 Jul; 98(14):1044-54. PubMed ID: 22591735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.